Location History:
- Mevaseret Zion, IL (2002 - 2019)
- Mevasseret Zion, IL (1997 - 2024)
Company Filing History:
3 out of 169 
2 out of 893 
Years Active: 1997-2024
Title: Hilla Giladi: Innovator in Cancer Therapy
Introduction
Hilla Giladi is a prominent inventor based in Mevasseret Zion, Israel, known for her significant contributions to cancer therapy through innovative research. With a total of five patents to her name, she has made remarkable strides in the field of molecular medicine.
Latest Patents
Among her latest patents, one notable invention is focused on tumor suppressive microRNAs for cancer therapy. This invention provides compositions that include agents capable of increasing the expression of endogenous tumor suppressive microRNAs in producing cells, which can subsequently affect target cancer cells. Another significant patent involves miR-122* as an active micro-RNA, which offers compositions and methods for treating various conditions, including cancer. This invention emphasizes methods for enhancing the expression, stability, and activity of p53 in target cells, ultimately leading to cancer cell death.
Career Highlights
Hilla has worked with esteemed organizations such as Hadasit Medical Research Services and Development Ltd. and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Her work in these institutions has been pivotal in advancing research and development in medical technologies.
Collaborations
Throughout her career, Hilla has collaborated with notable colleagues, including Eithan Galun and Amos B. Oppenheim. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Hilla Giladi's contributions to cancer therapy through her innovative patents and collaborations highlight her as a key figure in the field of medical research. Her work continues to inspire advancements in cancer treatment and molecular medicine.